Marked Enhanced Efficacy of Cyclosporin When Combined with Hyaluronic Acid: Evidence from Two T Cell-Mediated Models

Clinical Drug Investigation

Volumn 11, Issue 4, 1996, Pages 245-250

  Gowland, G ^a   Moore, A R ^a   Willis, D ^a   Willoughby, D A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AVRIDINE; CYCLOSPORIN A; GLYCOSAMINOGLYCAN; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; GRANULOMA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NONHUMAN; POLYARTHRITIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0029993704     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199611040-00008     Document Type: Article

References (10)

1. Bennet WM, Pulliam JP. Cyclosporin nephrotoxicity. Ann Intern Med 1983; 99: 851-65
2. Grecomoro G, Piccione F, Letizia G. Therapeutic synergism between hyaluronic acid and dexamethasone in the intra-articular treatment of osteoarthritis of the knee: a preliminary open study. Curr Med Res Opin 1992; 13: 49-55
3. Gandolfi SA, Massari A, Orsoni JG. Low molecular weight hyaluronate in the treatment of bacterial corneal ulcers. Graefe's Arch. Clin Exp Ophthalmol 1992; 230: 20-3
4. Moreira CA, Armstrong DK, Jellife RW, et al. In vitro and in vivo studies with sodium hyaluronate as a carrier for intravitreal gentamicin. Acta Ophthalmol 1991; 69: 45-50
5. Klein FS, He W, Shmizu S, et al. Hyaluronic acid enhances tritiated fluorouracil uptake in experimental cancer. Roy Soc Med Round Table Ser 1994; 33: 11-5
6. Taurog JD, Sandberg GP, Mahowald ML. The cellular basis of adjuvant arthritis. II. Characterisation of the cells mediating passive transfer. Cell Immunol 1983; 80: 198-205
7. Willoughby DA, Ryan GB. Evidence for an endogenous antigen in chronic inflammation. J Pathol 1970; 101: 233-9
8. Anderton SM, Van der Zee R, Prakhen B, et al. Activation of T-cells recognising self 60kDa heat shock protein can protect against experimental arthritis. J Exp Med 1995; 181: 943-52
9. Aruffo A, Stamenkovic I, Melnik M, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13
10. McCourt P, El B, Forsberg N. et al. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 1994; 269: 30081-4